ELI LILLY & Co - 22 Oct 2026 Form 3 Insider Report for Lycia Therapeutics, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
22 Oct 2026, 21:37:50 UTC
Prior SEC filing
08 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary
Filing notes and source

Key filing fact

ELI LILLY & Co filed Form 3 for Lycia Therapeutics, Inc. on 22 Oct 2026.

Key facts

  • This page summarizes ELI LILLY & Co's Form 3 filing for Lycia Therapeutics, Inc..
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 22 Oct 2026, 21:37.

Change

  • Previous filing in this sequence was filed on 08 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0000059478 Primary reporting owner

ELI LILLY & Co

Relationship
10%+ Owner
Address
LILLY CORPORATE CENTER, INDIANAPOLIS
Signature
/s/ Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary
Signature date
22 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,104,558
Date
22 Oct 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reported securities represent shares of Common Stock issuable upon mandatory conversion of convertible preferred stock in the Issuer's initial public offering but do not include shares of Common Stock purchased in the initial public offering, as such amount was not known at the time of this filing. See Remarks below.

SEC remarks

After giving effect to the closing of the Issuer's initial public offering, including the Reporting Person's purchase in such offering, the Reporting Person will cease to be a 10% Owner and, accordingly, will have no further Section 16 reporting obligations.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .